Read More
Idyllic Updates

Bristol-Myers Squibb’s ORENCIA Receives FDA Approval for Treatment of Active Psoriatic Arthritis (PsA) in Adults

ORENCIA is now approved for the treatment of three autoimmune diseases: Adult Rheumatoid Arthritis (RA) Juvenile Idiopathic Arthritis (JIA) Adult Psoriatic Arthritis (PsA) NEW Psoriatic arthritis (PsA) is a chronic, inflammatory disease that can affect both the skin...

Read more